Tumor Ablation Equipment Market Size Driven by Rising Demand for Minimally Invasive Cancer Treatments | Valuates Reports

Tumor Ablation Equipment Market Size
The global market for Tumor Ablation Equipment was valued at US$ 577 million in the year 2024 and is projected to reach a revised size of US$ 733 million by 2031, growing at a CAGR of 3.5% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-1V5046/Global_Tumor_Ablation_Equipment_Market_Insights_Forecast_to_2028

The tumor ablation equipment market is witnessing robust market growth, fueled by the rising incidence of cancer and the increasing preference for minimally invasive treatment options. Tumor ablation technologies, including microwave ablation (MWA), radiofrequency ablation (RFA), and cryoablation, are widely adopted due to their effectiveness in reducing tumor recurrence, shorter recovery times, and improved patient outcomes. With healthcare providers focusing on advanced oncology treatment solutions, the global tumor ablation equipment market size is expected to expand significantly in the coming years.

By type, microwave ablation (MWA) holds a notable market share owing to its high efficiency in treating large tumors and its shorter procedure times. Radiofrequency ablation (RFA) remains a widely adopted method due to its proven clinical outcomes and cost-effectiveness, especially in liver, lung, and kidney tumor treatments. Cryoablation is gaining traction for its ability to preserve surrounding healthy tissue and is increasingly used in prostate and renal cancer treatments. The "others" category includes emerging ablation technologies that are contributing to steady market growth.

By application, the hospital segment dominates the market size, driven by the availability of advanced medical infrastructure, skilled professionals, and a high patient base. Meanwhile, clinics are experiencing rising adoption of tumor ablation equipment due to the increasing availability of compact and cost-effective systems that enable outpatient cancer care. This growing adoption across healthcare facilities underpins a positive market outlook.

Looking ahead, the tumor ablation equipment market forecast points to significant opportunities across both developed and emerging markets. Rising investments in oncology research, integration of imaging technologies for precision ablation, and favorable reimbursement policies are expected to drive further market growth. With the increasing prevalence of cancer and technological advancements, the market share of tumor ablation equipment is set to expand, solidifying its role as a critical component in modern cancer treatment strategies.

Segment by Type

• MicrowaveAblation,MWA
• Radiofrequency Ablation,RFA
• Cryoablation
• Others

Segment by Application

• Hospitals
• Clinic

By Company

Medtronic, Johnson & Johnson, Boston Scientific Corporation, Ice Cure Medical Ltd., Galil Medical(BTG), HYGEA, Haifu, welfare, ECO, Nanjing Greatwall Information System Co., Micro-Tech

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-1V5046/global-tumor-ablation-equipment

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.